Department of Pharmacology, MVJ Medical College & Research Hospital, Hoskote 562 114, Karnataka, India.
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, GA 30322 Atlanta, United States.
CNS Neurol Disord Drug Targets. 2021;20(7):644-656. doi: 10.2174/1871527320666210218085816.
Epilepsy responds to pharmacotherapy in its initial stages. The response of some forms of epilepsy, like the refractory epilepsy, is extremely low. Surgical management of epilepsy is associated with complications, which necessitates the search for novel and modern strategies for the treatment of epilepsy. Neuroprotection and neuronal regeneration are the major targets that must be accomplished by the new strategies. Hematopoietic Stem Cell (HSCs) therapy for epilepsy has shown promising results in pre-clinical studies with marginal clinical effects. This review explores the characteristics, mechanism of action, and clinical significance of HSCs therapy for the treatment of epilepsy.
癫痫在其初始阶段对药物治疗有反应。一些形式的癫痫,如难治性癫痫,反应率极低。癫痫的手术治疗与并发症相关,这就需要寻找新的现代癫痫治疗策略。神经保护和神经元再生是新策略必须实现的主要目标。造血干细胞(HSCs)治疗癫痫在临床前研究中显示出有希望的结果,但临床效果有限。本综述探讨了 HSCs 治疗癫痫的特征、作用机制和临床意义。